These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4213267)

  • 1. Norepinephrine metabolism in the rat brain following acute and chronic administration of thyrotropin releasing hormone.
    Reigle TG; Avni J; Platz PA; Schildkraut JJ; Plotnikoff NP
    Psychopharmacologia; 1974 Jun; 37(1):1-6. PubMed ID: 4213267
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of acute and chronic administration of desmethylimipramine on the content of norepinephrine and other monoamines in the rat brain.
    Roffler-Tarlov S; Schildkraut JJ; Draskoczy PR
    Biochem Pharmacol; 1973 Nov; 22(22):2923-6. PubMed ID: 4148604
    [No Abstract]   [Full Text] [Related]  

  • 3. Time-dependent changes in brain 3 H-norepinephrine disappearance caused by L-DOPA administration.
    Hyyppä MT; Wurtman RJ
    Life Sci I; 1972 Aug; 11(15):713-21. PubMed ID: 4678968
    [No Abstract]   [Full Text] [Related]  

  • 4. Enhancement of brain noradrenaline and dopamine turnover by thyrotropin-releasing hormone and its analogue NS-3 in mice and rats.
    Itoh Y; Yamazaki A; Ukai Y; Yoshikuni Y; Kimura K
    Pharmacol Toxicol; 1996 Jun; 78(6):421-8. PubMed ID: 8829205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of norepinephrine, serotonin and dopamine in rat brain with stress.
    Bliss EL; Ailion J; Zwanziger J
    J Pharmacol Exp Ther; 1968 Nov; 164(1):122-34. PubMed ID: 4387046
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of thyrotropin-releasing hormone on catecholamine concentration in various structures of the rat brain.
    Niimi M; Takahara J; Fujino H; Aoki Y
    Folia Psychiatr Neurol Jpn; 1983; 37(2):121-7. PubMed ID: 6423471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of L-dopa on accumulation and efflux of monoamines in particles of rat brain homogenates.
    Ng LK; Colburn RW; Kopin IJ
    J Pharmacol Exp Ther; 1972 Nov; 183(2):316-25. PubMed ID: 5083548
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacological analysis of shaking behavior induced by enkephalins, thyrotropin-releasing hormone or serotonin in rats: evidence for different mechanisms.
    Drust EG; Connor JD
    J Pharmacol Exp Ther; 1983 Jan; 224(1):148-54. PubMed ID: 6401333
    [No Abstract]   [Full Text] [Related]  

  • 9. Increase in monoamine concentration in rat brain following melatonin administration.
    Wendel OT; Waterbury LD; Pearce LA
    Experientia; 1974 Oct; 30(10):1167-8. PubMed ID: 4435125
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of perinatal undernutrition on the metabolism of catecholamines in the rat brain.
    Shoemaker WJ; Wurtman RJ
    J Nutr; 1973 Nov; 103(11):1537-47. PubMed ID: 4148058
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes in brain catecholamines and spontaneous locomotor activity in response to thyrotropin releasing hormone.
    Agarwal RA; Rastogi RB; Singhal RL
    Res Commun Chem Pathol Pharmacol; 1976 Dec; 15(4):743-52. PubMed ID: 12549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of delta-9-tetrahydrocannabinol on the metabolism of norepinephrine in rat brain.
    Schildkraut JJ; Efron DH
    Psychopharmacologia; 1971; 20(2):191-6. PubMed ID: 5090538
    [No Abstract]   [Full Text] [Related]  

  • 13. Proceedings: Thyrotropin-releasing hormone: activation of cerebral noradrenaline turnover.
    Keller HH; Bartholini G
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R46. PubMed ID: 4276583
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of 6-hydroxydopamine on brain norepinephrine and dopamine evidence for selective degeneration of catecholamine neurons.
    Breese GR; Traylor TD
    J Pharmacol Exp Ther; 1970 Sep; 174(3):413-20. PubMed ID: 5456173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Social environment and brain biogenic amine metabolism in rats.
    Stolk JM; Conner RL; Barchas JD
    J Comp Physiol Psychol; 1974 Aug; 87(2):203-7. PubMed ID: 4279254
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of metoclopramide on turnover of brain dopamine noradrenaline and 5-hydroxytryptamine.
    Peringer E; Jenner P; Marsden CD
    J Pharm Pharmacol; 1975 Jun; 27(6):442-4. PubMed ID: 237096
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhancement of cerebral noradrenaline turnover by thyrotropin-releasing hormone.
    Keller HH; Bartholini G; Pletscher A
    Nature; 1974 Apr; 248(448):528-9. PubMed ID: 4207412
    [No Abstract]   [Full Text] [Related]  

  • 18. Alterations in consummatory behavior following intracisternal injection of 6-hydroxydopamine.
    Breese GR; Smith RD; Cooper BR; Grant LD
    Pharmacol Biochem Behav; 1973; 1(3):319-28. PubMed ID: 4775860
    [No Abstract]   [Full Text] [Related]  

  • 19. Norepinephrine pools in rat brain: differences in turnover rates and pathways of metabolism.
    Schildkraut JJ; Draskoczy PR; Lo PS
    Science; 1971 May; 172(3983):587-8. PubMed ID: 5555080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daily fluctuation (circadian and ultradian) in biogenic amines of the rat brain.
    Scheving LE; Harrison WH; Gordon P; Pauly JE
    Am J Physiol; 1968 Jan; 214(1):166-73. PubMed ID: 5634522
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.